aTyr Pharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $10.7M | $11.1M | $22.5M | $10.0M | $2.3M | $17.0M | $9.2M | $23.0M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $80.2M | $82.0M | $103.0M | $80.9M | $113.6M | $35.5M | $31.9M | $50.8M |
| Property, Plant & Equipment | $4.3M | $4.9M | $5.5M | $3.1M | $543.0K | $899.0K | $1.3M | $1.9M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $93.0M | $96.8M | $120.7M | $95.8M | $115.5M | $38.7M | $36.2M | $52.7M |
| Liabilities | ||||||||
| Accounts Payable | $3.9M | $4.3M | $3.5M | $3.1M | $1.0M | $1.4M | $847.0K | $1.0M |
| Total Current Liabilities | $15.1M | $15.0M | $16.4M | $13.9M | $6.0M | $5.9M | $12.9M | $10.8M |
| Long-Term Debt | — | — | — | — | — | — | — | $8.3M |
| Total Liabilities | $25.5M | $26.8M | $30.0M | $24.3M | $6.2M | $7.1M | $15.0M | $19.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-606.2M | $-532.0M | $-468.0M | $-417.6M | $-372.3M | $-338.5M | $-322.3M | $-298.7M |
| Total Stockholders' Equity | $67.5M | $70.0M | $90.7M | $71.5M | $109.3M | $31.7M | $21.2M | $33.7M |